IDEAS home Printed from https://ideas.repec.org/h/nbr/nberch/15346.html

Taking Stock: The Past and Future of Biomedical Research Funding

In: Economics of Science

Author

Listed:
  • Bhaven N. Sampat

Abstract

No abstract is available for this item.

Suggested Citation

  • Bhaven N. Sampat, 2026. "Taking Stock: The Past and Future of Biomedical Research Funding," NBER Chapters, in: Economics of Science, National Bureau of Economic Research, Inc.
    • Handle: RePEc:nbr:nberch:15346
    as

    Download full text from publisher

    File URL: http://www.nber.org/chapters/c15346.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Matt Marx & Aaron Fuegi, 2022. "Reliance on science by inventors: Hybrid extraction of in‐text patent‐to‐article citations," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 31(2), pages 369-392, April.
    2. Donna K. Ginther & Misty L. Heggeness, 2020. "Administrative Discretion in Scientific Funding: Evidence from a Prestigious Postdoctoral Training Program," NBER Working Papers 26841, National Bureau of Economic Research, Inc.
    3. Pierre Azoulay & Joshua S. Graff Zivin & Gustavo Manso, 2011. "Incentives and creativity: evidence from the academic life sciences," RAND Journal of Economics, RAND Corporation, vol. 42(3), pages 527-554, September.
    4. Deepak Hegde & Bhaven Sampat, 2015. "Can Private Money Buy Public Science? Disease Group Lobbying and Federal Funding for Biomedical Research," Management Science, INFORMS, vol. 61(10), pages 2281-2298, October.
    5. Bhaven N. Sampat, 2010. "When Do Applicants Search for Prior Art?," Journal of Law and Economics, University of Chicago Press, vol. 53(2), pages 399-416, May.
    6. Daniel P. Gross & Bhaven N. Sampat, 2025. "The Therapeutic Consequences of the War: World War II and the 20th-Century Expansion of Biomedicine," NBER Working Papers 33457, National Bureau of Economic Research, Inc.
    7. Pierre Azoulay & Daniel P. Gross & Bhaven N. Sampat, 2025. "Indirect Cost Recovery in US Innovation Policy: History, Evidence, and Avenues for Reform," NBER Chapters, in: Entrepreneurship and Innovation Policy and the Economy, volume 5, pages 133-182, National Bureau of Economic Research, Inc.
    8. Pierre Azoulay & Wesley H. Greenblatt, 2025. "Does Peer Review Penalize Scientific Risk Taking? Evidence from NIH Grant Renewals," NBER Working Papers 33495, National Bureau of Economic Research, Inc.
    9. Filippo Mezzanotti & Timothy Simcoe, 2022. "Innovation and Appropriability: Revisiting the Role of Intellectual Property," Working Papers 22-09, Center for Economic Studies, U.S. Census Bureau.
    10. Margaret E. Blume-Kohout, 2012. "Does Targeted, Disease‐Specific Public Research Funding Influence Pharmaceutical Innovation?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 31(3), pages 641-660, June.
    11. William D. Nordhaus, 2002. "The Health of Nations: The Contribution of Improved Health to Living Standards," NBER Working Papers 8818, National Bureau of Economic Research, Inc.
    12. Ginther, Donna K. & Heggeness, Misty L., 2020. "Administrative discretion in scientific funding: Evidence from a prestigious postdoctoral training program✰," Research Policy, Elsevier, vol. 49(4).
    13. Pierre Azoulay & Joshua S Graff Zivin & Danielle Li & Bhaven N Sampat, 2019. "Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 86(1), pages 117-152.
    14. Toole, Andrew A, 2007. "Does Public Scientific Research Complement Private Investment in Research and Development in the Pharmaceutical Industry?," Journal of Law and Economics, University of Chicago Press, vol. 50(1), pages 81-104, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Kok, Holmer & Faems, Dries & de Faria, Pedro, 2022. "Pork Barrel or Barrel of Gold? Examining the performance implications of earmarking in public R&D grants," Research Policy, Elsevier, vol. 51(7).
    2. Margaret K. Kyle, 2020. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," Innovation Policy and the Economy, University of Chicago Press, vol. 20(1), pages 95-123.
    3. Yi, Guanting, 2025. "Health insurance expansion and academic production: The case of Medicare Part D legislation," Social Science & Medicine, Elsevier, vol. 367(C).
    4. Mikko Packalen & Jay Bhattacharya, 2018. "Does the NIH Fund Edge Science?," NBER Working Papers 24860, National Bureau of Economic Research, Inc.
    5. Kevin A. Bryan & Heidi L. Williams, 2021. "Innovation: Market Failures and Public Policies," NBER Working Papers 29173, National Bureau of Economic Research, Inc.
    6. Pierre Azoulay & Danielle Li, 2020. "Scientific Grant Funding," NBER Chapters, in: Innovation and Public Policy, pages 117-150, National Bureau of Economic Research, Inc.
    7. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).
    8. Yang, Alex J., 2024. "Unveiling the impact and dual innovation of funded research," Journal of Informetrics, Elsevier, vol. 18(1).
    9. Graddy-Reed, Alexandra, 2020. "Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D," Research Policy, Elsevier, vol. 49(8).
    10. Pierre Azoulay & Danielle Li, 2020. "Scientific Grant Funding," NBER Working Papers 26889, National Bureau of Economic Research, Inc.
    11. repec:osf:socarx:hpmxd_v1 is not listed on IDEAS
    12. Jianwei DANG & Kazuyuki MOTOHASHI & Quihan ZHAO, 2025. "Patent Information Disclosure and Market Reactions: Empirical investigation by using text-based novelty and impact indicators," Discussion papers 25097, Research Institute of Economy, Trade and Industry (RIETI).
    13. Ke, Qing, 2020. "Technological impact of biomedical research: The role of basicness and novelty," Research Policy, Elsevier, vol. 49(7).
    14. Bryan, Kevin A. & Ozcan, Yasin & Sampat, Bhaven, 2020. "In-text patent citations: A user's guide," Research Policy, Elsevier, vol. 49(4).
    15. Kyle, Margaret K. & Ridley, David B. & Zhang, Su, 2017. "Strategic interaction among governments in the provision of a global public good," Journal of Public Economics, Elsevier, vol. 156(C), pages 185-199.
    16. Pierre Azoulay & Joshua S. Graff Zivin & Bhaven N. Sampat, 2011. "The Diffusion of Scientific Knowledge across Time and Space: Evidence from Professional Transitions for the Superstars of Medicine," NBER Chapters, in: The Rate and Direction of Inventive Activity Revisited, pages 107-155, National Bureau of Economic Research, Inc.
    17. Thomas H. W. Ziesemer, 2021. "The Effects of R&D Subsidies and Publicly Performed R&D on Business R&D: A Survey," Hacienda Pública Española / Review of Public Economics, IEF, vol. 236(1), pages 171-205, March.
    18. Yaqub, Ohid & Coburn, Josie & Moore, Duncan A.Q., 2024. "Research-targeting, spillovers, and the direction of science: Evidence from HIV research-funding," Research Policy, Elsevier, vol. 53(8).
    19. Byungchul Choi & M. V. Shyam Kumar & Fabio Zambuto, 2016. "Capital Structure and Innovation Trajectory: The Role of Debt in Balancing Exploration and Exploitation," Organization Science, INFORMS, vol. 27(5), pages 1183-1201, October.
    20. Azoulay, Pierre & Heggeness, Misty & Kao, Jennifer, 2025. "Medical research and health care finance: Evidence from Academic Medical Centers," Research Policy, Elsevier, vol. 54(2).
    21. Kyle Myers, 2020. "The Elasticity of Science," American Economic Journal: Applied Economics, American Economic Association, vol. 12(4), pages 103-134, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nbr:nberch:15346. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: the person in charge (email available below). General contact details of provider: https://edirc.repec.org/data/nberrus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.